°æºÏ´ëÇб³º´¿ø 2019³âµµ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Á¦3Â÷ ¿¬¼ö±³À° : 2019-08-17±³À°ÀÏÀÚ : 2019-08-17
±³À°Àå¼Ò : °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2019³âµµ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Á¦3Â÷ ¿¬¼ö±³À°ÁÖÃÖ±â°ü : ´ëÇѽŰæ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ë±¸°æºÏÁöȸ
´ã´çÀÚ : ÀÌÁ¤È£
¿¬¶ôó : 053-420-5647
À̸ÞÀÏ :
blackfox72@naver.com ±³À°Á¾·ù : ½Å°æ¿Ü°ú
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 14:30~14:45 Stroke Mimics and Chameleons ±èÁø¿í(µ¿±¹´ë)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 14:45~15:00 Inflammatory Musculoskeletal Disease ÀÌâ±Ô(°è¸í´ë)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 15:00~15:15 Endovascular Treatment of Cerebral Aneurysm Á¤¿µÁø(¿µ³²´ë)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 15:15~15:30 How to Overcome Complications during Coiling of Intracranial Aneurysms °û¿µ¼®(´ë±¸°¡Å縯´ë)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 15:45~16:00 Special Speech for Retirement ÃÖ±âȯ(´ë±¸°¡Å縯´ë)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 16:00~16:30 US Guided Intervention for Lumbosacral Region Àü¿µÈÆ(°æºÏ´ë)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 16:30~17:00 Physiatric Approach to Spinal Pain ¼º´öÇö(¼º±Õ°ü´ë »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 17:20~17:40 Denosumab: Mechanism and Clinical Outcomes ±èÇý¼ø(°è¸í´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 17:40~18:00 New Antiresorptive Drugs vs Anabolic Agents ±èºÎ°æ(°í½Å´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 08-17 °æºÏ´ëÇб³º´¿ø 6º´µ¿ 10Ãþ ´ë°´ç 18:00~18:20 °ñ´Ù°øÁõ Ä¡·á ¾àÁ¦ÀÇ ½ÇÁ¦ ÀÓ»ó Àû¿ë(Áõ·Ê Æ÷ÇÔ) Á¶´ëö(°æºÏ´ë)